Medical Developments International CEO stepping down
- Medical Developments International CEO Brent MacGregor announced his intention to step down from his leadership role.
- The company share price remained unchanged at $0.40 following the leadership transition announcement.
- CFO Anita James will step into the interim chief executive role to maintain strategic momentum.
Medical Developments International (ASX:MVP) announced that CEO Brent MacGregor will step down from his position.
The leadership change follows six years of leadership by MacGregor, during which the business expanded international adoption of its core Penthrox product.
"It has been a privilege to lead MVP for the past six years," said Medical Developments International CEO Brent MacGregor.
The board appointed CFO Anita James as interim CEO effective Oct. 15, while MacGregor will remain in an advisory role until Nov. 15 to assist with the transition.
Following the announcement, the Medical Developments International share price was unchanged at $0.40.
The company stated that the search process for a permanent chief executive officer has commenced.
Medical Developments International recently secured regulatory approvals for paediatric indication of Penthrox in the United Kingdom and the European Union.
